Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Another point of view on 2017 PRETEXT.

Pariente D, Franchi-Abella S, Cellier C, Branchereau S, Taque S, Laithier V, Aerts I, Chardot C, Brugières L.

Pediatr Radiol. 2018 Nov;48(12):1817-1819. doi: 10.1007/s00247-018-4227-4. Epub 2018 Aug 14. No abstract available.

PMID:
30109379
2.

Another point of view on 2017 PRETEXT: reply to Pariente et al.

Towbin AJ, Meyers RL, Woodley H, Miyazaki O, Weldon CB, Morland B, Hiyama E, Czauderna P, Roebuck DJ, Tiao GM.

Pediatr Radiol. 2018 Nov;48(12):1820-1822. doi: 10.1007/s00247-018-4228-3. Epub 2018 Aug 15. No abstract available.

PMID:
30112622
3.

Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.

Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P.

Lancet Oncol. 2017 Jan;18(1):122-131. doi: 10.1016/S1470-2045(16)30598-8. Epub 2016 Nov 22.

4.

Hepatoblastoma. Clinical experience at a single institution using the Siopel staging system.

Leal-Leal CA, Imaz-Olguín V, Robles-Castro J, Shalkow-Klincovstein J, Palacios-Acosta JM.

Ann Hepatol. 2010 Jan-Mar;9(1):75-9.

PMID:
20308725
5.

PRETEXT II-III multifocal hepatoblastoma: significance of resection of satellite lesions irrespective of their disappearance after chemotherapy.

Qureshi SS, Bhagat M, Kembhavi S, Vora T, Ramadwar M, Talole S.

Pediatr Surg Int. 2015 Jun;31(6):573-9. doi: 10.1007/s00383-015-3713-0. Epub 2015 Apr 23.

PMID:
25904441
6.

Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation.

Meyers RL, Tiao G, de Ville de Goyet J, Superina R, Aronson DC.

Curr Opin Pediatr. 2014 Feb;26(1):29-36. doi: 10.1097/MOP.0000000000000042. Review.

PMID:
24362406
7.

Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.

Suita S, Tajiri T, Takamatsu H, Mizote H, Nagasaki A, Inomata Y, Hara T, Okamura J, Miyazaki S, Kawakami K, Eguchi H, Tsuneyoshi M; Committee for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.

J Pediatr Surg. 2004 Feb;39(2):195-8; discussion 195-8. Review.

PMID:
14966739
8.

Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study.

Aronson DC, Schnater JM, Staalman CR, Weverling GJ, Plaschkes J, Perilongo G, Brown J, Phillips A, Otte JB, Czauderna P, MacKinlay G, Vos A.

J Clin Oncol. 2005 Feb 20;23(6):1245-52.

PMID:
15718322
9.

Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.

Shanmugam N, Scott JX, Kumar V, Vij M, Ramachandran P, Narasimhan G, Reddy MS, Kota V, Munirathnam D, Kelgeri C, Sundaram K, Rela M.

Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26249. Epub 2016 Oct 26.

PMID:
27781375
10.

Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.

Hishiki T, Matsunaga T, Sasaki F, Yano M, Ida K, Horie H, Kondo S, Watanabe K, Oue T, Tajiri T, Kamimatsuse A, Ohnuma N, Hiyama E.

Pediatr Surg Int. 2011 Jan;27(1):1-8. doi: 10.1007/s00383-010-2708-0.

PMID:
20922397
11.

2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT).

Towbin AJ, Meyers RL, Woodley H, Miyazaki O, Weldon CB, Morland B, Hiyama E, Czauderna P, Roebuck DJ, Tiao GM.

Pediatr Radiol. 2018 Apr;48(4):536-554. doi: 10.1007/s00247-018-4078-z. Epub 2018 Feb 9. Review.

PMID:
29427028
12.

Mortality and morbidity in primarily resected hepatoblastomas in Japan: Experience of the JPLT (Japanese Study Group for Pediatric Liver Tumor) trials.

Hiyama E, Hishiki T, Watanabe K, Ida K, Yano M, Oue T, Iehara T, Hoshino K, Koh K, Tanaka Y, Kurihara S, Ueda Y, Onitake Y.

J Pediatr Surg. 2015 Dec;50(12):2098-101. doi: 10.1016/j.jpedsurg.2015.08.035. Epub 2015 Aug 28.

PMID:
26388131
13.

Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.

Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH.

Pediatr Blood Cancer. 2009 Dec;53(6):1016-22. doi: 10.1002/pbc.22088.

14.

Hepatoblastoma throughout SIOPEL trials - clinical lessons learnt.

Czauderna P.

Front Biosci (Elite Ed). 2012 Jan 1;4:470-9.

PMID:
22201887
15.

Liver transplantation for hepatoblastoma.

Faraj W, Dar F, Marangoni G, Bartlett A, Melendez HV, Hadzic D, Dhawan A, Mieli-Vergani G, Rela M, Heaton N.

Liver Transpl. 2008 Nov;14(11):1614-9. doi: 10.1002/lt.21586.

16.

Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.

Maibach R, Roebuck D, Brugieres L, Capra M, Brock P, Dall'Igna P, Otte JB, De Camargo B, Zsiros J, Zimmermann A, Aronson D, Childs M, Scopinaro M, Morland B, Plaschkes J, Czauderna P, Perilongo G.

Eur J Cancer. 2012 Jul;48(10):1543-9. doi: 10.1016/j.ejca.2011.12.011. Epub 2012 Jan 13.

PMID:
22244829
17.

Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group.

Malogolowkin MH, Katzenstein HM, Meyers RL, Krailo MD, Rowland JM, Haas J, Finegold MJ.

J Clin Oncol. 2011 Aug 20;29(24):3301-6. doi: 10.1200/JCO.2010.29.3837. Epub 2011 Jul 18.

18.

Guidelines for surgical treatment of hepatoblastoma in the modern era--recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL).

Czauderna P, Otte JB, Aronson DC, Gauthier F, Mackinlay G, Roebuck D, Plaschkes J, Perilongo G; Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL).

Eur J Cancer. 2005 May;41(7):1031-6.

PMID:
15862752
19.

[Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].

Häberle B, Bode U, von Schweinitz D.

Klin Padiatr. 2003 May-Jun;215(3):159-65. German.

PMID:
12778356
20.

Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.

Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P, Dicks-Mireaux C, Phillips A, Vos A, Plaschkes J.

Eur J Cancer. 2000 Jul;36(11):1418-25.

PMID:
10899656

Supplemental Content

Support Center